Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 21385 | 421 | 23.4 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
| 822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
| 21385 | 1 | AMLODIPINE//NIFEDIPINE GITS//MODERN APPROACH TO THE TREATMENT OF HYPERTENSION MATH TRIAL | 421 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | AMLODIPINE | authKW | 943289 | 29% | 11% | 123 |
| 2 | NIFEDIPINE GITS | authKW | 165569 | 3% | 21% | 11 |
| 3 | MODERN APPROACH TO THE TREATMENT OF HYPERTENSION MATH TRIAL | authKW | 145059 | 0% | 100% | 2 |
| 4 | NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM GITS | authKW | 145059 | 0% | 100% | 2 |
| 5 | NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM | authKW | 81592 | 1% | 38% | 3 |
| 6 | ADRENERGIC INNERVATION OF MICROVESSELS | authKW | 72530 | 0% | 100% | 1 |
| 7 | ADVERSE EVENTS POSTMARKETING SURVEILLANCE PRESCRIPTION EVENT MONITORING | authKW | 72530 | 0% | 100% | 1 |
| 8 | AMDODIPINE | authKW | 72530 | 0% | 100% | 1 |
| 9 | ANAESTHESIA EDUC UNIT | address | 72530 | 0% | 100% | 1 |
| 10 | ASYMMETRIC 1 4 DIHYDROPYRIDINES | authKW | 72530 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 3085 | 34% | 0% | 143 |
| 2 | Pharmacology & Pharmacy | 2322 | 44% | 0% | 184 |
| 3 | Peripheral Vascular Diseases | 1869 | 20% | 0% | 84 |
| 4 | Medicine, General & Internal | 141 | 10% | 0% | 42 |
| 5 | Medicine, Research & Experimental | 33 | 5% | 0% | 19 |
| 6 | Toxicology | 11 | 2% | 0% | 10 |
| 7 | Geriatrics & Gerontology | 3 | 1% | 0% | 3 |
| 8 | Chemistry, Medicinal | 1 | 1% | 0% | 5 |
| 9 | Gerontology | 0 | 0% | 0% | 1 |
| 10 | Urology & Nephrology | 0 | 1% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ANAESTHESIA EDUC UNIT | 72530 | 0% | 100% | 1 |
| 2 | AUTONOM DYSFUNCT UNIT | 72530 | 0% | 100% | 1 |
| 3 | CAMCARE HLTH EDUC | 72530 | 0% | 100% | 1 |
| 4 | CHEM ENGN TECNOL | 72530 | 0% | 100% | 1 |
| 5 | CORP REGULATORY COMPLIANCE QUAL ASSURANCE | 72530 | 0% | 100% | 1 |
| 6 | DRUG THER Y MONITORING UNIT | 72530 | 0% | 100% | 1 |
| 7 | INTERNAL MED MED EXPT ONCOL | 72530 | 0% | 100% | 1 |
| 8 | KRASNODAR REG MED | 72530 | 0% | 100% | 1 |
| 9 | MAXWELL AF BASE | 72530 | 0% | 100% | 1 |
| 10 | MED HLTH OUTCOMES | 72530 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLINICAL DRUG INVESTIGATION | 22450 | 6% | 1% | 26 |
| 2 | JOURNAL OF HUMAN HYPERTENSION | 11395 | 6% | 1% | 24 |
| 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 9512 | 9% | 0% | 38 |
| 4 | CARDIOVASCULAR DRUGS AND THERAPY | 4516 | 3% | 1% | 11 |
| 5 | AMERICAN JOURNAL OF HYPERTENSION | 3965 | 4% | 0% | 18 |
| 6 | CLINICAL THERAPEUTICS | 2852 | 3% | 0% | 14 |
| 7 | POSTGRADUATE MEDICAL JOURNAL | 2771 | 4% | 0% | 17 |
| 8 | JOURNAL OF HYPERTENSION | 2689 | 5% | 0% | 19 |
| 9 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH | 1885 | 1% | 1% | 5 |
| 10 | AMERICAN HEART JOURNAL | 1808 | 5% | 0% | 19 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | HARIA, M , WAGSTAFF, AJ , (1995) AMLODIPINE - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE.DRUGS. VOL. 50. ISSUE 3. P. 560-586 | 71 | 58% | 104 |
| 2 | NAYLER, WG , (1997) AMLODIPINE - AN OVERVIEW.CLINICAL DRUG INVESTIGATION. VOL. 13. ISSUE . P. 1-11 | 45 | 58% | 10 |
| 3 | MURDOCH, D , HEEL, RC , (1991) AMLODIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN CARDIOVASCULAR-DISEASE.DRUGS. VOL. 41. ISSUE 3. P. 478-505 | 47 | 57% | 152 |
| 4 | BURGES, RA , DODD, MG , (1990) AMLODIPINE.CARDIOVASCULAR DRUG REVIEWS. VOL. 8. ISSUE 1. P. 25 -44 | 33 | 75% | 55 |
| 5 | CLAVIJO, GA , DECLAVIJO, IV , WEART, CW , (1994) AMLODIPINE - A NEW CALCIUM-ANTAGONIST.AMERICAN JOURNAL OF HOSPITAL PHARMACY. VOL. 51. ISSUE 1. P. 59-68 | 33 | 52% | 30 |
| 6 | LEVINE, CB , FAHRBACH, KR , FRAME, D , CONNELLY, JE , ESTOK, RP , STONE, LR , LUDENSKY, V , (2003) EFFECT OF AMLODIPINE ON SYSTOLIC BLOOD PRESSURE.CLINICAL THERAPEUTICS. VOL. 25. ISSUE 1. P. 35-57 | 33 | 31% | 20 |
| 7 | KOZYREV, VN , (1993) CLINICAL ASPECTS OF AMLODIPIN PHARMACOKINETICS.TERAPEVTICHESKII ARKHIV. VOL. 65. ISSUE 9. P. 75-80 | 21 | 72% | 0 |
| 8 | DIBIANCO, R , SCHOOMAKER, FW , SINGH, JB , AWAN, NA , BENNETT, T , CANOSA, FL , KAWANISHI, DT , BAMRAH, VS , GLASSER, SP , BARRY, W , (1992) AMLODIPINE COMBINED WITH BETA-BLOCKADE FOR CHRONIC ANGINA - RESULTS OF A MULTICENTER, PLACEBO-CONTROLLED, RANDOMIZED DOUBLE-BLIND-STUDY.CLINICAL CARDIOLOGY. VOL. 15. ISSUE 7. P. 519-524 | 16 | 89% | 24 |
| 9 | GAMBINI, C , ANTONICELLI, R , GESUITA, R , PACIARONI, E , (1997) HAEMODYNAMIC EFFECTS OF AMLODIPINE IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION.CLINICAL DRUG INVESTIGATION. VOL. 13. ISSUE . P. 12-16 | 13 | 93% | 1 |
| 10 | HABELER, G , LENZHOFER, R , PALL, H , TOMASCHEK, A , ZIEBARTSCHROTH, A , ZIRM, B , GANZINGER, U , (1992) SAFETY AND EFFICACY OF AMLODIPINE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION - A LONG-TERM STUDY WITH A NEW CALCIUM-ANTAGONIST.WIENER KLINISCHE WOCHENSCHRIFT. VOL. 104. ISSUE 1. P. 16-20 | 17 | 85% | 2 |
Classes with closest relation at Level 1 |